Skip to Main content Skip to Navigation
Journal articles

Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver.

Abstract : Liver tropism potentially leading to massive hepatocyte transduction and hepatotoxicity still represents a major drawback to adenovirus (Ad)-based gene therapy. We previously demonstrated that substitution of the hexon hypervariable region 5 (HVR5), the most abundant capsid protein, constituted a valuable platform for efficient Ad retargeting. The use of different mouse strains revealed that HVR5 substitution also led to dramatically less adenovirus liver transduction and associated toxicity, whereas HVR5-modified Ad were still able to transduce different cell lines efficiently, including primary hepatocytes. We showed that HVR5 modification did not significantly change Ad blood clearance or liver uptake at early times. However, we were able to link the lower liver transduction to enhanced HVR5-modified Ad liver clearance and impaired use of blood factors. Most importantly, HVR5-modified vectors continued to transduce tumors in vivo as efficiently as their wild-type counterparts. Taken together, our data provide a rationale for future design of retargeted vectors with a safer profile.
Document type :
Journal articles
Complete list of metadata

Cited literature [42 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-00315859
Contributor : Michel Perricaudet <>
Submitted on : Saturday, May 30, 2020 - 11:06:34 PM
Last modification on : Thursday, June 17, 2021 - 3:50:35 AM

File

Vigant_2008_Molec Ther_1.pdf
Publisher files allowed on an open archive

Licence


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

Collections

CNRS | DAM | CEA | IGR | FNCLCC | CELIA | INSERM

Citation

Frédéric Vigant, Delphyne Descamps, Betsy Jullienne, Stéphanie Esselin, Elisabeth Connault, et al.. Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver.. Molecular Therapy, Nature Publishing Group, 2008, 16 (8), pp.1474-80. ⟨10.1038/mt.2008.132⟩. ⟨hal-00315859⟩

Share

Metrics

Record views

318

Files downloads

156